# BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

> **NCT05120271** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sotio Biotech Inc.** · enrollment: 7 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Squamous Cell Carcinoma of the Lung
- Merkel Cell Carcinoma
- Myxoid/Round Cell Liposarcoma

## Interventions

- **BIOLOGICAL:** CAR-GPC3 T Cells

## Key facts

- **NCT ID:** NCT05120271
- **Lead sponsor:** Sotio Biotech Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-10-26
- **Primary completion:** 2025-10-24
- **Final completion:** 2042-12
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05120271

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05120271, "BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05120271. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*